Journal of Inflammation Research

COPE logo
ISSN: 1178-7031

Liver and Gall Bladder Inflammation


Section Editor(s):
Dr Türker, Department of Internal Medicine, Istanbul Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
Professor Zhu, Department of Hepatobiliary, Pancreatic and Splenic Surgery, Beijing Chao-Yang Hospital, Capital Medical University, China

This section covers liver and gall bladder inflammation including viral-, autoimmune-, and drug- and -alcohol induced hepatitis metabolic dysfunction-associated fatty liver disease (MAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD) or non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver disease or hepatic steatosis, acute liver injury, cirrhosis, liver fibrosis, cholecystitis, cholestasis and Wilson’s disease.

Latest articles in Liver and Gall Bladder Inflammation:

- 13 records -

Clinical Value of Inflammatory Indexes in Predicting Post-Transplantation Prognosis in Hepatocellular Carcinoma: A Retrospective Cohort Study

Wang HX, Ye XY, Jiang T, Lyu SC, He Q, Ji ZL, Lang R

Journal of Inflammation Research 2026, 19:610101

Published Date: 3 July 2026

Association Between Systemic Inflammation Indices and Recurrence Risk in Primary Budd-Chiari Syndrome

Shen Z, Ni M, Liu Y, Zhang H, Xing X, Zhang Q, Zu M, Li Y, Li S

Journal of Inflammation Research 2026, 19:579101

Published Date: 10 June 2026

Glasgow Prognostic Score Predicts Hepatic Recompensation in Decompensated Primary Biliary Cholangitis: A Multicenter Cohort Study

Huang M, Dai A, Gao L, Wu C, Zou W, Duan D, Niu J, Tang Y, Yang J, Lei H

Journal of Inflammation Research 2026, 19:601389

Published Date: 4 June 2026

Transcriptomic and Proteomic Analyses Identify THBS2, VWF, NFASC, and AKR1B10 as Diagnostic Biomarkers for Advanced Fibrosis in NAFLD

Ding S, Liu Y, Liu Z, Chu F, Lu B, Xu L

Journal of Inflammation Research 2026, 19:569506

Published Date: 22 May 2026

Integrated Machine Learning and Multi-Omics Analysis Identifies Mitophagy-Related Core Genes and Mechanisms in Non-Alcoholic Fatty Liver Disease

Yuan Y, Zhang T, Song C, Lin C, Sun Y, Tang H

Journal of Inflammation Research 2026, 19:575586

Published Date: 24 March 2026

The Role of Neutrophils in Non-Alcoholic Fatty Liver Disease: Mechanisms and Clinical Significance

Zhang F, Li W

Journal of Inflammation Research 2026, 19:585447

Published Date: 4 March 2026

PANoptosis as a Potential Therapeutic Target in Drug-Induced Liver Injury: A Narrative Review

Zhang X, Zhou Z, Xie Z, Chen J, Deng Y, Fang Y, Deng J, Ye X

Journal of Inflammation Research 2026, 19:569771

Published Date: 8 January 2026

The Role of Galectin-3 in Liver Inflammation and Fibrosis

Lurje I, Biegel DK, Zhang IW, Tacke F

Journal of Inflammation Research 2026, 19:572637

Published Date: 8 January 2026

The Therapeutic Effects of Active Components from Food-Medicine Plants on Liver Fibrosis

Sun C, Chen B, Hu Y, Wang S, Chen T, Xu M, Gong Q

Journal of Inflammation Research 2026, 19:573983

Published Date: 7 January 2026

Development and Validation of an Explainable Machine Learning Model for Gangrenous Cholecystitis Prediction: A Multicenter Retrospective Study

Hu Y, Chen Y, Zhao H

Journal of Inflammation Research 2025, 18:17747-17758

Published Date: 17 December 2025

SIRT1 Enhancement is Required for the Induction of Anti-Inflammatory Effect of Micheliolide in Carbon Tetrachloride Induced Liver Fibrosis in Mice

Jin C, Jiang A, Chang J, Hu Y, Wang Y, Zhao R, Shi J, Wu H, Han Z, Liu Z

Journal of Inflammation Research 2025, 18:16231-16245

Published Date: 19 November 2025


Read more articles

Other sections from this journal: